Now available in Connecticut, Maine, Massachusetts, New Hampshire, New Jersey, New York, Pennsylvania, and Rhode Island

Series B Press Release

General Catalyst leads funding round joined by .406 Ventures, Valtruis, Mass General Brigham Ventures, and Hopelab Foundation to bolster insurance-based mental health program availability in new markets.

First Annual Outcomes Report

InStride Health, a specialty pediatric anxiety and OCD treatment provider, released its first annual outcomes report. Based on treatment of over 350 patients, InStride Health demonstrated clinically meaningful results of its coordinated care model.

InStride Health Launches

InStride Health, technology-enhanced mental health treatment for children and adolescents struggling with moderate to severe anxiety and OCD, announces its formal launch. Working in collaboration with McLean Hospital—America’s top-ranked psychiatric hospital and an affiliate of Harvard Medical School.

Contact us if you have a question.

Start the application process here.